简介：the lancet oncology rss feed: current issue. the lancet oncology, impact factor 9.608, considers high-quality original research, reviews, and opinion pieces in any area of clinical or translational oncology that have potential to substantially improve clinical practice. submissions judged eligible for our fast-track service are peer-reviewed in 72h, and, if accepted, published in 4-8 weeks.

原站：http://www.thelancet.com/journals/lanonc

指数：

“The Lancet Oncology”的内容更新

累计：981 篇（自 2009-04-22 起）

更新：约7篇/周，最后更新13 天前

The Lancet Oncology

[Editorial] Ovarian cancer: breaking the silence

the heterogeneous nature of cancer makes it a very difficult disease to manage. although great progress has been made against many types of cancer (as highlighted by recent mortality data from the american cancer society), treatment of others has shown little change in the past few decades. ovarian cancer, for example, has traditionally lagged behind: re... (13 天前)

http://inezha.com/w/9dd4d05c

The Lancet Oncology

[Comment] Don't pick the loser: lessons from the Gep

in the lancet oncology, michael untch and colleagues report the first efficacy results from the geparquinto (gbg 44) study, a randomised phase 3 trial of lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-based and taxane-based chemotherapy. 620 women with her2-positive operable or locally advanced breast cancer were randomly assi... (13 天前)

http://inezha.com/w/bfmmc05l

The Lancet Oncology

[Comment] Easing acceleration of head and neck chemo

in the past 20 years, management of locoregionally advanced head and neck cancer has evolved from often devastating surgical resection towards radiotherapy, intensified either by altered fractionation or by addition of concurrent chemotherapy, with the aim of cure with functional preservation of organs. a key expectation was that intensification of radio... (13 天前)

http://inezha.com/w/t7w6m05p

The Lancet Oncology

[Comment] VEGF Trap for the treatment of malignant a

about 10% of all cases of ascites are caused by a malignant disease. in developed countries the most common neoplasm associated with ascites is ovarian cancer. the pathophysiology of malignant ascites is multifactorial, and its molecular pathogenesis is only poorly understood. ascites formation can result from obstruction of lymph vessels by tumour cells... (13 天前)

http://inezha.com/w/xqdj305d

The Lancet Oncology

[Comment] Nasopharyngeal cancer: a promising future

the results of the intergroup 00-99 trial represented a key turning point for the management of nasopharyngeal cancer and heralded a new era of concurrent chemoradiation regimens. these findings were built on by the addition of intensity-modulated radiotherapy to tackle local failure. as a result, 90% local control rates for nasopharyngeal cancer can be ... (13 天前)

http://inezha.com/w/y0m0w056

The Lancet Oncology

[Comment] Biliary-tract cancer: improving therapy by

until recently, for most patients, biliary-tract cancer could be managed only by supportive care, with resection possible in a few individuals. in parallel with improved surgical procedures and a multidisciplinary approach, oncological treatment has evolved and now offers options with survival benefit. the continued improvement of systemic treatment is a... (13 天前)

http://inezha.com/w/0jwqak5u

The Lancet Oncology

[Comment] Prostate cancer therapy: finding the right

more than 30 years ago willet whitmore, one of the pioneers in urological oncology, asked the question: “if cure is necessary, is it possible, and if cure is possible, is it necessary?” such questioning can be applied to the use of androgen suppression therapy. androgen suppression is an extremely powerful treatment that can help control cancers that r... (13 天前)

http://inezha.com/w/e9d7dk5s

订阅者 ( 2 )

相关订阅源